Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marian Stevens-Kroef

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Blood|June 25, 2010
Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patientsAnnemiek Broyl, Dirk Hose, Henk Lokhorst, et al.
Annals of Hematology|June 22, 2018
Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15-60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trialsFrédéric Baron, Marian Stevens-Kroef, Michal Kicinski, et al.
Blood Advances|December 22, 2020
Prognostic and predictive performance of R-ISS with SKY92 in older patients with multiple myeloma: the HOVON-87/NMSG-18 trialRowan Kuiper, Sonja Zweegman, Mark van Duin, et al.
American Journal of Human Genetics|July 8, 2021
Optical genome mapping enables constitutional chromosomal aberration detectionTuomo Mantere, Kornelia Neveling, Céline Pebrel-Richard, et al.
American Journal of Hematology|April 2, 2020
Impact of the type of anthracycline and of stem cell transplantation in younger patients with acute myeloid leukaemia: Long-term follow up of a phase III studyFrédéric Baron, Fabio Efficace, Laura Cannella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2012
Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65/ GMMG-HD4 trialPieter Sonneveld, Ingo G H Schmidt-Wolf, Bronno van der Holt, et al.
The Lancet. Haematology|November 1, 2023
10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trialMichael Lübbert, Pierre W Wijermans, Michal Kicinski, et al.
Haematologica|January 25, 2020
Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multi-center studyAlexander C Leeksma, Panagiotis Baliakas, Theodoros Moysiadis, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Blood|June 25, 2010
Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patientsAnnemiek Broyl, Dirk Hose, Henk Lokhorst, et al.
Annals of Hematology|June 22, 2018
Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15-60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trialsFrédéric Baron, Marian Stevens-Kroef, Michal Kicinski, et al.
Blood Advances|December 22, 2020
Prognostic and predictive performance of R-ISS with SKY92 in older patients with multiple myeloma: the HOVON-87/NMSG-18 trialRowan Kuiper, Sonja Zweegman, Mark van Duin, et al.
American Journal of Human Genetics|July 8, 2021
Optical genome mapping enables constitutional chromosomal aberration detectionTuomo Mantere, Kornelia Neveling, Céline Pebrel-Richard, et al.
American Journal of Hematology|April 2, 2020
Impact of the type of anthracycline and of stem cell transplantation in younger patients with acute myeloid leukaemia: Long-term follow up of a phase III studyFrédéric Baron, Fabio Efficace, Laura Cannella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2012
Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65/ GMMG-HD4 trialPieter Sonneveld, Ingo G H Schmidt-Wolf, Bronno van der Holt, et al.
The Lancet. Haematology|November 1, 2023
10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trialMichael Lübbert, Pierre W Wijermans, Michal Kicinski, et al.
Haematologica|January 25, 2020
Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multi-center studyAlexander C Leeksma, Panagiotis Baliakas, Theodoros Moysiadis, et al.
Pageof 2